Key result
NT-proBNP levels at hospital admission predicted 30-day mortality in patients with community acquired pneumonia with an AUC of 0.735 (95% CI 0.642-0.828; p<0.001).
Why the study?
Clinical risk scores for pneumonia prognosis are complex and error-prone, and the prognostic role of NT-proBNP in community acquired pneumonia remains unclear.
Does NT-proBNP level predict 30-day mortality and ICU admission in inpatients with community acquired pneumonia?
Cohort
Does NT-proBNP level predict 30-day mortality and ICU admission in inpatients with community acquired pneumonia?
Effect estimate: AUC 0.735 (95% CI 0.642-0.828)
p-value: p=<0.001
NT-proBNP levels at admission predict 30-day mortality and ICU admission in CAP patients with accuracy comparable to the PSI score.
No takes yet. Share an insight, caveat, or question.
May aid early risk stratification in CAP inpatients; leaves open incremental value over PSI pending validation.
Akpınar et al. (2019) conducted a cohort in Community acquired pneumonia. NT-proBNP level was evaluated on All-cause mortality within the first 30 days after hospital admission (AUC 0.735, 95% CI 0.642-0.828, p=<0.001). NT-proBNP levels at hospital admission predicted 30-day mortality in patients with community acquired pneumonia with an AUC of 0.735 (95% CI 0.642-0.828; p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: